MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CSTL — Castle Biosciences, Inc. Common Stock

Nasdaq

Castle Biosciences, Inc. Common Stock

CompareBack to Screener
$35.56
+0.31(+0.87%)
O
35.56
H
35.92
L
34.75
V
167.71K
⏱️ End-of-day dataAs of Oct 2, 2026

CSTL — Financial Statements

Historical 2-Year Statements
Financial Metric / Line ItemQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Fiscal Date2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Periodquarterlyquarterlyquarterlyquarterlyquarterlyquarterly
Year2,026.002,025.002,025.002,025.002,025.002,024.00
Cash And Cash Equivalents63,764.00116,729.0085,556.0082,233.0089,689.00119,709.00
Other Short Term Investments197,921.00182,776.00201,986.00193,697.00185,462.00173,421.00
Accounts Receivable42,264.0043,382.0049,482.0052,311.0056,353.0051,218.00
Inventory10,461.0010,254.008,650.008,366.006,849.008,135.00
Other Current Assets14,491.007,956.0011,895.0012,061.0011,035.007,671.00
Total Current Assets328,901.00361,097.00357,569.00348,668.00349,388.00360,154.00
Properties48,026.0047,829.0046,918.0041,903.0034,892.0035,217.00
Land And Improvements7,245.007,245.007,245.007,245.007,245.007,245.00
Machinery Furniture Equipment10,453.009,568.009,092.009,252.009,088.008,847.00
Construction In Progress10,751.0051,059.0038,810.0031,870.0014,958.009,614.00
Leases14,875.0014,834.0014,810.0014,808.0014,624.0014,616.00
Accumulated Depreciation-19,864.00-18,297.00-16,839.00-15,515.00-14,220.00-12,833.00
Goodwill108,047.00110,266.00112,541.00114,817.0088,596.00116,921.00
Intangible Assets86,647.0088,882.0091,157.0093,433.0067,212.0095,537.00
Other Non Current Assets6,199.005,647.003,332.002,373.002,266.002,146.00
Total Non Current Assets218,904.00217,459.00205,217.00196,061.00152,327.00171,081.00
Total Assets547,805.00578,556.00562,786.00544,729.00501,715.00531,235.00
Accounts Payable15,038.0018,711.0012,211.0013,181.008,502.006,901.00
Accrued Expenses6,725.005,887.005,829.005,190.005,917.004,918.00
Short Term Debt2,921.001,742.001,449.003,515.002,546.001,943.00
Pensions19,407.0039,211.0031,975.0025,942.0017,857.0033,780.00
Other Current Liabilities4,670.003,126.002,599.001,869.001,172.00774.00
Total Current Liabilities48,761.0068,677.0055,308.0050,890.0037,274.0049,392.00
Long Term Debt33,803.0035,171.0035,690.0033,837.0023,298.0024,401.00
Deferred Liabilities2,325.002,335.003,242.003,126.00837.001,607.00
Other Non Current Liabilities1,500.001,500.001,500.001,500.00N/AN/A
Total Non Current Liabilities37,628.0039,006.0040,432.0038,463.0024,135.0026,008.00
Total Liabilities86,389.00107,683.0095,740.0089,353.0061,409.0075,400.00
Common Stock30.0030.0029.0029.0029.0028.00
Retained Earnings-238,806.00-224,284.00-221,952.00-221,451.00-225,974.00-200,126.00
Other Shareholders Equity-63.00267.00240.0039.00131.00230.00
Total Shareholders Equity461,416.00470,873.00467,046.00455,376.00440,306.00455,835.00
Additional Paid In Capital700,255.00694,860.00688,729.00676,759.00666,120.00655,703.00
Tax PayableN/AN/A1,245.001,193.001,280.001,076.00
Investments And AdvancesN/AN/AN/AN/A5,570.00N/A